| payload |
{"created_at":"2026-04-11T15:08:00.060 {"created_at":"2026-04-11T15:08:00.060011+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/eli-lilly-isnt-replacing-zepbound-its-building-obesity-empire","value":{"fp":"a9b22de2381be43f","kind":"unusual_volume","published_at":"2026-04-11T14:50:00+00:00","source":"Nasdaq Markets","summary":"Key PointsEli Lilly's newer weight-loss medicines will help cement its dominance in the market.","tickers":[],"title":"Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire","url":"https://www.nasdaq.com/articles/eli-lilly-isnt-replacing-zepbound-its-building-obesity-empire"}}... |